Boston University
Dietary serine and glycine restriction impedes oral cancer evolution through epigenetic inhibition of cell plasticity
Abstract
dc:description.abstractHead and neck cancer with its major subsite, oral squamous cell carcinoma (OSCC), is a devastating malignancy, associated with high morbidity and mortality, with limited treatment options. OSCC is characterized by heterogeneous cell states, or cell plasticity, including cancer stem cells and cells with epithelial-to-mesenchymal transition (EMT) phenotypes, which drive aggressive cancer traits, metastasis, and therapeutic resistance. Given that recent studies have highlighted nutritional interventions as potential treatment strategies for cancer with the availability of amino acids affecting tumor metabolism and cell plasticity through epigenetic changes in the chromatin landscape, we investigated the role of dietary serine restriction in OSCC cell fate decisions. To determine the role of nutrition in OSCC evolution, we utilized several human OSCC cell lines, which accurately represent the molecular, genomic, and transcriptomic landscape seen in human tumor subtypes. We show that under serine starvation conditions, OSCC cells significantly slowed proliferation concomitant with a change in morphology from mesenchymal- to epithelial-like phenotypes, compared to cells grown in complete medium. Changes in proliferation were associated with few changes in global metabolomics, suggesting that serine starvation does not have great impact on global cellular metabolism. Serine starvation was associated with a statistically significant increase in the steady-state mRNA and enzyme levels of the serine synthesis pathway enzymes, indicating that OSCC cells rely on exogenous serine for growth resembling serine auxotrophs. The observed switch from exogenous serine uptake to endogenous serine synthesis was also accompanied by an increase in α-ketoglutarate (αKG) concentration, a biproduct of the serine synthesis pathway PSAT1 enzyme. Given that αKG serves as a co-substrate for nuclear αKG-dependent dioxygenases (αKGDD), which can direct cell fate through histone modifications, this suggested that dietary serine impacted OSCC cell identities. Using unbiased bulk RNA-sequencing, we found that human OSCC cells depend on exogenous serine to sustain plastic cell states. Enrichment analysis of serine starvation gene signature showed a significant decrease in EMT hallmark genes. Additionally, we found an increased association of serine starvation gene signatures with a terminal epithelial keratinization signature, further suggesting a switch in cell fate from mesenchymal-like to differentiated cell states. By profiling the chromatin landscape under serine deprivation conditions via Cleavage Under Targets & Release Under Nuclease (CUT&RUN)-sequencing, we observed a decrease in H3K27me3 at differentiation genes. Since the repressive histone mark H3K27me3 can be demethylated by αKGDD, and de-represses differentiation genes in epithelial cells, this finding provided a mechanistic link between the observed change in OSCC cell phenotypes under dietary serine starvation conditions. Additionally, along with decrease in H3K27me3, we found the loss of H3K4me3, a mark of open chromatin structure known to promote stemness genes and aggressive cancer traits. Collectively, these findings indicate that dietary serine restriction reduces aggressive cell states while promoting re-acquisition of differentiated epithelial cell phenotypes. The above findings were validated using an orthotopic OSCC isograft model in C57BL/6 mice that confirmed that dietary serine restriction reduces tumor growth which was associated with decreased abundance of H3K27me3 and H3K4me3 marks. Collectively, these results provide greater understanding into the interplay between serine metabolism and epigenetic drivers of OSCC tumorigenesis. This research is likely to provide new insights into how modulation of dietary serine may represent a new treatment strategy and/or enhance the efficacy of current therapeutic options for OSCC patients.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Molecular and Translational Medicine
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Jankowski, Stacy A.
- Advisor dc:contributor.advisor
-
- Kukuruzinska, Maria A.
- ORCID dc:identifier.orcid
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53167